Key facts
- Squadron Capital Management LLC filed SCHEDULE 13G/A for NextCure, Inc. Common Stock, $0.001 par value per share (NXTC).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Squadron Master Fund LP | 9.9% | 271,127 | 0 | 271,127 | /s/ Matthew Sesterhenn | Partner, Squadron Partners LLC, its General Partner | |
| Squadron Capital Management LLC | 9.9% | 271,127 | 0 | 271,127 | /s/ Matthew Sesterhenn | Partner | |
| Matthew Sesterhenn | 9.9% | 271,127 | 0 | 271,127 | /s/ Matthew Sesterhenn | Matthew Sesterhenn | |
| William Blank | 9.9% | 271,127 | 0 | 271,127 | /s/ William Blank | William Blank |
CIK / CUSIP context first